The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> July 12, 2019

Interview with the CEO: electroCore, Inc. (NASDAQ:ECOR)

Amato, Francis R.
Francis R. Amato is Chief Executive Officer of electroCore, Inc. Prior to being the Chief Executive Officer and joining electroCore in 2012, Mr. Amato spent 22 years in the pharmaceutical industry, most recently at Merck, where he served as Vice President of the Specialty Commercial Operations Group within Global Human Health. Mr. Amato has extensive commercial experience in health care, serving previously as Executive Director, Global Business Operations at Schering-Plough; Business Unit Lead, Oncology at Ligand Pharmaceuticals; National Sales Director, Specialty Managed Markets at Pfizer Inc.; and National Sales Director, Hospitals at Pharmacia Corporation. Mr. Amato started his career with The Upjohn Company as a sales representative in New York City. Prior to joining the pharmaceutical industry, he was an infantry medic in the 82nd Airborne Division within the U.S. Army. Mr. Amato received a Master of Business Administration from Pepperdine University, Graziadio School of Management and a Bachelor of Arts in political science from St. John’s University. Profile
Word count: 3,389

TWST: For those who aren't familiar with the previous interview we did with you, tell us about electroCore’s core technology, gammaCore, and update us as to whether

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc
CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
AI Opportunities Expand to Industrial, Utilities and Energy Sectors
India Fund Manager Expects Discretionary Spending to Grow
Inefficiency in Ex-US Markets Creates Opportunity to Buy at a Discount
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy